COLUMBUS CIRCLE INVESTORS - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
COLUMBUS CIRCLE INVESTORS ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$8,071,000
-41.0%
80,990
-32.0%
0.44%
-24.5%
Q4 2019$13,687,000
+16.4%
119,122
+27.8%
0.59%
+36.1%
Q3 2019$11,759,000
+29.9%
93,224
+23.9%
0.43%
+78.5%
Q2 2019$9,054,000
-63.4%
75,234
-69.6%
0.24%
-65.5%
Q4 2018$24,744,000
-28.4%
247,320
-18.0%
0.70%
+1.6%
Q3 2018$34,575,000
+47.9%
301,752
+15.8%
0.69%
+42.9%
Q2 2018$23,378,000
+60.3%
260,678
+30.8%
0.48%
+63.2%
Q1 2018$14,581,000199,3030.30%
Other shareholders
HAEMONETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders